New Trial Unlikely After $70M Neovasc Verdict, Judge Says

A federal judge in Boston said Monday she was reluctant to order a new trial after a $70 million trade secrets verdict against Neovasc, and also unlikely to grant rival medical...

Already a subscriber? Click here to view full article